Trial intelligence / Profile preview

Metformin in Adolescent PCOS

NCT06015594Completed

Sponsor
Università degli Studi di Cagliari
Start
Jan 2015
Primary completion
Aug 2019
Modality
Small Molecules
01

Overview

Open-label trial of metformin in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Università degli Studi di Cagliari. Primary endpoints: Insulin resistance change at 3 years and Androgen levels change at 3 years. Started Jan 2015; status: completed.

02

Drugs

metformin
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on NCT06015594.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06015594.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call